MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
and cash...
-$40,359K
Depreciation and
amortization
$30,005K
Accrued rebates,
returns and discounts
$23,062K
Inventories
-$9,678K
Loss on assertio
therapeutics divestiture
-$8,174K
Provisions for inventory
$4,510K
Stock-based compensation
$3,454K
Impairment of intangible
assets
$1,700K
Prepaid and other assets
-$1,209K
Amortization of debt issuance
costs
$475K
Accretion of interest
income from short-term...
-$93K
Proceeds from maturities
of short-term...
$115,383K
Net cash (used in)
provided by operating...
-$28,182K
Net cash used in
investing activities
-$11,988K
Net cash used in
financing activities
-$189K
Canceled cashflow
$82,360K
Canceled cashflow
$115,383K
Accounts receivable
$65,990K
Purchases of short-term
investments
$119,197K
Payments related to the
vesting and settlement...
$189K
Net loss
-$30,375K
Accounts payable and
other accrued...
-$13,292K
Payment of contingent
consideration
$450K
Recurring fair value
measurements of assets and...
$435K
Assertio therapeutics
divestiture
$8,174K
Back
Back
Cash Flow
source: myfinsight.com
Assertio Holdings, Inc. (ASRT)
Assertio Holdings, Inc. (ASRT)